|
Date of decision
|
28 October 2002
|
|
|
Case number
|
T 0890/00
- 3.3.2
|
|
|
Application number
|
94920360.8
|
|
|
|
|
|
|
Title of the application
|
Anti-angiogenic compositions and methods of use
|
|
|
Applicant name
|
Angiotech Pharmaceuticals, Inc., et al
|
|
|
Opponent name
|
(I) Schering AG
(II) Focal, Inc.
(III) Inflow Dynamics AG
(IV) STS Biopolymers Inc.
(V) Abbott Vascular Devices Limited
|
|
|
|
|
Keywords
Remittal to the first instance for further prosecution- New main
request not examined for all EPC requirements
Apportionment of costs (no): more appropriate for decision at
end of further first instance proceedings
|
|
|
|
|
